Literature DB >> 27037209

Determining the natural history of pancreatic cystic neoplasms: a Manitoban cohort study.

Jon Broughton1, Jeremy Lipschitz2, Michael Cantor3, Dana Moffatt3, Ahmed Abdoh2, Andrew McKay4.   

Abstract

BACKGROUND: Most pancreatic cystic neoplasms (PCN) are thought to harbor a low malignant potential. This historical cohort study attempts to describe the natural history of these lesions in a provincial cohort, to assess the safety of non-surgical management. Pathological diagnosis of malignancy was the primary outcome measure of interest.
METHODS: All adult patients (age 18+) with PCN seen between 2000 and 2012 by the two main institutions in Manitoba were included in this study. PCN were graded as high and low risk, which dictated initial treatment plan (surgery or observation). Predictors of initial surgical treatment, delayed surgery in the observation group and the clinical/radiological predictors of malignancy were determined.
RESULTS: 497 patients were included in this study. 43 (8.7%) high-risk lesions underwent initial surgery, with 13 (30.2%) cases of malignancy discovered. 450 (90.5%) low-risk cysts were observed for a median of 17.3 months (range: 0.00-142.3). 29 (6.4%) cases of delayed surgery occurred, with malignancy discovered in five (17.2%).
CONCLUSIONS: This study supports current selection criteria for management of PCNs. Due to the low incidence of malignancy in low-risk PCN, it appears that long-term observation is safe and should be the treatment modality of choice in the absence of high-risk features.
Copyright © 2016 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27037209      PMCID: PMC4814595          DOI: 10.1016/j.hpb.2015.11.001

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  25 in total

1.  International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas.

Authors:  Masao Tanaka; Carlos Fernández-del Castillo; Volkan Adsay; Suresh Chari; Massimo Falconi; Jin-Young Jang; Wataru Kimura; Philippe Levy; Martha Bishop Pitman; C Max Schmidt; Michio Shimizu; Christopher L Wolfgang; Koji Yamaguchi; Kenji Yamao
Journal:  Pancreatology       Date:  2012-04-16       Impact factor: 3.996

2.  The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Seiko Hirono; Masaji Tani; Manabu Kawai; Ken-ichi Okada; Motoki Miyazawa; Atsushi Shimizu; Yuji Kitahata; Hiroki Yamaue
Journal:  Ann Surg       Date:  2012-03       Impact factor: 12.969

Review 3.  Intraductal papillary mucinous neoplasms of the pancreas: making a disposition using the natural history.

Authors:  L William Traverso; Toshiyuki Moriya; Yasushi Hashimoto
Journal:  Curr Gastroenterol Rep       Date:  2012-04

4.  Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas: a multicenter study in Japan.

Authors:  Hiroyuki Maguchi; Satoshi Tanno; Nobumasa Mizuno; Keiji Hanada; Go Kobayashi; Takashi Hatori; Yoshihiko Sadakari; Taketo Yamaguchi; Kosuke Tobita; Ryuichiro Doi; Akio Yanagisawa; Masao Tanaka
Journal:  Pancreas       Date:  2011-04       Impact factor: 3.327

5.  Imaging features to distinguish malignant and benign branch-duct type intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis.

Authors:  Kyung Won Kim; Seong Ho Park; Junhee Pyo; Soon Ho Yoon; Jae Ho Byun; Moon-Gyu Lee; Katherine M Krajewski; Nikhil H Ramaiya
Journal:  Ann Surg       Date:  2014-01       Impact factor: 12.969

6.  Clinicopathologic features and outcomes of pancreatic cysts during a 12-year period.

Authors:  Joo Won Chung; Moon Jae Chung; Jeong Youp Park; Seungmin Bang; Si Young Song; Jae Bock Chung; Seung Woo Park
Journal:  Pancreas       Date:  2013-03       Impact factor: 3.327

Review 7.  Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis.

Authors:  Neeraj Anand; Kartik Sampath; Bechien U Wu
Journal:  Clin Gastroenterol Hepatol       Date:  2013-02-13       Impact factor: 11.382

8.  Prevalence of unsuspected pancreatic cysts on MDCT.

Authors:  Thomas A Laffan; Karen M Horton; Alison P Klein; Bruce Berlanstein; Stanley S Siegelman; Satomi Kawamoto; Pamela T Johnson; Elliot K Fishman; Ralph H Hruban
Journal:  AJR Am J Roentgenol       Date:  2008-09       Impact factor: 3.959

9.  Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Thomas Schnelldorfer; Michael G Sarr; David M Nagorney; Lizhi Zhang; Thomas C Smyrk; Rui Qin; Suresh T Chari; Michael B Farnell
Journal:  Arch Surg       Date:  2008-07

10.  Pancreatic cystic neoplasms: predictors of malignant behavior and management.

Authors:  Ehab Atef; Ayman El Nakeeb; Ehab El Hanafy; Mohamed El Hemaly; Emad Hamdy; Ahmed El-Geidie
Journal:  Saudi J Gastroenterol       Date:  2013 Jan-Feb       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.